The hepatitis C virus persistence: How to evade the immune system?

Journal of Biosciences

Volumn 28, Issue 3, 2003, Pages 287-304

  Pavio, Nicole ^a   Lai, Michael M C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cell signalling; Hepatitis C virus; Immune system

Indexed keywords

COMPLEMENT; CYTOKINE; EPITOPE; INTERFERON;

HEPATITIS; IMMUNE SYSTEM;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; B LYMPHOCYTE; CELL PROLIFERATION; CHRONIC HEPATITIS; GENETIC HETEROGENEITY; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; PERSISTENT VIRUS INFECTION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; VIRUS PATHOGENESIS;

ANIMALIA; HEPATITIS C VIRUS;

EID: 0037399329     PISSN: 02505991     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02970148     Document Type: Review

References (163)

1. Agnello V, Abel G, Elfahal M, Knight G B and Zhang Q X 1999 Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor; Proc. Natl. Acad. Sci. USA 96 12766-12771
2. Ali N and Siddiqui A 1995 Interaction of polypyrimidine tract-binding protein with the 5′ noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation; J. Virol. 69 6367-6375
3. Ali N and Siddiqui A 1997 The La antigen binds 5′ noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation; Proc. Natl. Acad. Sci. USA 94 2249-2254
4. Araya V, Rakela J and Wright T 1997 Hepatitis C after orthotopic liver transplantation; Gastroenterology 112 575-582
5. Arima N, Kao C Y, Licht T, Padmanabhan R, Sasaguri Y and Padmanabhan R 2001 Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A; J. Biol. Chem. 276 12675-12684
6. Auffermann-Gretzinger S, Keeffe E B and Levy S 2001 Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection; Blood 97 3171-3176
7. Bain C, Fatmi A, Zoulim F, Zarski J P, Trepo C and Inchauspe G 2001 Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection; Gastroenterology 120 512-524
8. Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, Schaff Z, Chapman M J, Miyamura T and Brechot C 1997 Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets; Proc. Natl. Acad. Sci. USA 94 1200-1205
9. Baumert T F, Ito S, Wong D T and Liang T J 1998 Hepatitis C virus structural proteins assemble into viruslike particles in insect cells; J. Virol. 72 3827-3836
10. Bell D, Young J W and Banchereau J 1999 Dendritic cells; Adv. Immunol. 72 255-324
11. Bergqvist A and Rice C M 2001 Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein; J. Virol. 75 772-781
12. Biro L, Varga L, Par A, Nemesanszky E, Csepregi A, Telegdy L, Ibranyi E, David K, Horvath G, Szentgyorgyi L, Nagy I, Dalmi L, Abonyi M, Fust G and Horanyi M 2000 Changes in the acute phase complement component and IL-6 levels in patients with chronic hepatitis C receiving interferon alpha-2b; Immunol. Lett. 72 69-74
13. Blight K J, Kolykhalov A A and Rice C M 2000 Efficient initiation of HCV RNA replication in cell culture; Science 290 1972-1974
14. Booth J C, Kumar U, Webster D, Monjardino J and Thomas H C 1998 Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients; Hepatology 27 223-227
15. Borowski P, Oehlmann K, Heiland M and Laufs R 1997 Non-structural protein 3 of hepatitis C virus blocks the distribution of the free catalytic subunit of cyclic AMP-dependent protein kinase; J. Virol. 71 2838-2843
16. Boyer J C and Haenni A L 1994 Infectious transcripts and cDNA clones of RNA viruses; Virology 198 415-426
17. Bronowicki J P, Loriot M A, Thiers V, Grignon Y, Zignego A L and Brechot C 1998 Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice; Hepatology 28 211-218
18. Brown E A, Zhang H, Ping L H and Lemon S M 1992 Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs; Nucleic Acids Res. 20 5041-5045
19. Bukh J and Miller R H 1994 Diagnostic and clinical implications of the different genotypes of hepatitis C virus; Hepatology 20 256-259
20. Bukh J, Miller R H and Purcell R H 1995 Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes; Semin Liver Dis. 15 41-63
21. Carrere-Kremer S, Montpellier-Pala C, Cocquerel L, Wychowski C, Penin F and Dubuisson J 2002 Subcellular localization and topology of the p7 polypeptide of hepatitis C virus; J. Virol. 76 3720-3730
22. Castelain S, Khorsi H, Roussel J, Francois C, Jaillon O, Capron D, Penin F, Wychowski C, Meurs E and Duverlie G 2002 Variability of the nonstructural 5A protein of hepatitis C virus type 3a isolates and relation to interferon sensitivity; J. Infect Dis. 185 573-583
23. Cerny A and Chisari F V 1994 Immunological aspects of HCV infection; Intervirology 37 119-125
24. Cerny A and Chisari F V 1999 Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence; Hepatology 30 595-601
25. Cerny A, Ferrari C and Chisari F V 1994 The class I-restricted cytotoxic T lymphocyte response to predetermined epitopes in the hepatitis B and C viruses; Curr. Top. Microbiol. Immunol. 189 169-186
26. Chang J, Yang S H, Cho Y G, Hwang S B, Hahn Y S and Sung Y C 1998 Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene; J. Virol. 72 3060-3065
27. Chang K M, Thimme R, Melpolder J J, Oldach D, Pemberton J, Moorhead-Loudis J, McHutchison J G, Alter H J and Chisari F V 2001 Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection; Hepatology 33 267-276
28. Chen C M, You L R, Hwang L H and Lee Y H 1997 Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor; J. Virol. 71 9417-9426
29. Cheng J C, Chang M F and Chang S C 1999 Specific interaction between the hepatitis C virus NS5B RNA polymerase and the 3′ end of the viral RNA; J. Virol. 73 7044-7049
30. Choo Q L, Kuo G, Weiner A J, Overby L R, Bradley D W and Houghton M 1989 Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome; Science 244 359-362
31. Cocquerel L, Duvet S, Meunier J C, Pillez A, Cacan R, Wychowski C and Dubuisson J 1999 The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum; J. Virol. 73 2641-2649
32. Cocquerel L, Meunier J C, Pillez A, Wychowski C and Dubuisson J 1998 A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2; J. Virol. 72 2183-2191
33. Colombo M 1998 The role of hepatitis C virus in hepatocellular carcinoma; Rec. Results Cancer Res. 154 337-344
34. Cotler S J, Reddy K R, McCone J, Wolfe D L, Liu A, Craft T R, Ferris M W, Conrad A J, Albrecht J, Morrissey M, Ganger D R, Rosenblate H, Blatt L M, Jensen D M and Taylor M W 2001 An analysis of acute changes in interleukin-6 levels after treatment of hepatitis C with consensus interferon; J. Interferon Cytokine Res. 21 1011-1019
35. Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, Mosca M, Filliponi F, Brunetto R M, Bonino F, Abrignani S and Valiante N M 2002 Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein; J. Exp. Med. 195 35-41
36. Cucchiarini M, Kammer A R, Grabscheid B, Diepolder H M, Gerlach T J, Gruner N, Santantonio T, Reichen J, Pape G R and Cerny A 2000 Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection; Cell. Immunol. 203 111-123
37. De Francesco R, Neddermann P, Tomei L, Steinkuhler C, Gallinari P and Folgori A 2000 Biochemical and immunologic properties of the nonstructural proteins of the hepatitis C virus: implications for development of antiviral agents and vaccines; Semin Liver Dis. 20 69-83
38. Deleersnyder V, Pillez A, Wychowski C, Blight K, Xu J, Hahn Y S, Rice C M and Dubuisson J 1997 Formation of native hepatitis C virus glycoprotein complexes; J. Virol. 71 697-704
39. Delhem N, Sabile A, Gajardo R, Podevin P, Abadie A, Blaton M A, Kremsdorf D, Beretta L and Brechot C 2001 Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein; Oncogene 20 5836-5845
40. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F and Sato C 1996 Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection; N. Engl. J. Med. 334 77-81
41. Erickson A L, Kimura Y, Igarashi S, Eichelberger J, Houghton M, Sidney J, McKinney D, Sette A, Hughes A L and Walker C M 2001 The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes; Immunity 15 883-895
42. Failla C, Tomei L and De Francesco R 1994 Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins; J. Virol. 68 3753-3760
43. Farci P, Bukh J and Purcell R H 1997 The quasispecies of hepatitis C virus and the host immune response; Springer Semin Immunopathol. 19 5-26
44. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder J C, Strazzera A, Chien D Y, Munoz S J, Balestrieri A, Purcell R H and Alter H J 2000 The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies; Science 288 339-344
45. Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter H J and Purcell R H 1996 Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein; Proc. Natl. Acad. Sci. USA 93 15394-15399
46. Ferri C, Monti M, La Civita L, Careccia G, Mazzaro C, Longombardo G, Lombardini F, Greco F, Pasero G, Bombardieri S et al 1994 Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia; Eur. J. Clin. Invest. 24 781-784
47. Flint M, Maidens C, Loomis-Price L D, Shotton C, Dubuisson J, Monk P, Higginbottom A, Levy S and McKeating J A 1999 Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81; J. Virol. 73 6235-6244
48. Forns X, Purcell R H and Bukh J 1999 Quasispecies in viral persistence and pathogenesis of hepatitis C virus; Trends Microbiol. 7 402-410
49. Fournier C, Sureau C, Coste J, Ducos J, Pageaux G, Larrey D, Domergue J and Maurel P 1998 In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus; J. Gen. Virol. 79 2367-2374
50. Gale M J, Korth M J, Tang N M, Tan S L, Hopkins D A, Dever T E, Polyak S J, Gretch D R and Katze M G 1997 Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein; Virology 230 217-227
51. Gale M J, Kwieciszewski B, Dossett M, Nakao H and Katze M G 1999 Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase; J. Virol. 73 6506-6516
52. Garcia-Retortillo M, Forns X, Feliu A, Moitinho E, Costa J, Navasa M, Rimola A and Rodes J 2002 Hepatitis C virus kinetics during and immediately after liver transplantation; Hepatology 35 680-687
53. Gerotto M, Dal Pero F, Pontisso P, Noventa F, Gatta A and Alberti A 2000 Two PKR inhibitor HCV proteins correlate with early but not sustained response to interferon; Gastroenterology 119 1649-1655
54. Ghosh A K, Steele R, Meyer K, Ray R and Ray R B 1999 Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth; J. Gen. Virol. 80 1179-1183
55. Gontarek R R, Gutshall L L, Herold K M, Tsai J, Sathe G M, Mao J, Prescott C and Del Vecchio A M 1999 hnRNP C and polypyrimidine tract-binding protein specifically interact with the pyrimidine-rich region within the 3′NTR of the HCV RNA genome; Nucleic Acids Res. 27 1457-1463
56. Grakoui A, McCourt D W, Wychowski C, Feinstone S M and Rice C M 1993 A second hepatitis C virus-encoded proteinase; Proc. Natl. Acad. Sci. USA 90 10583-10587
57. Guo J T, Bichko V V and Seeger C 2001 Effect of alpha interferon on the hepatitis C virus replicon; J. Virol. 75 8516-8523
58. Hahn C S, Cho Y G, Kang B S, Lester I M and Hahn Y S 2000 The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line; Virology 276 127-137
59. He X S, Rehermann B, Lopez-Labrador F X, Boisvert J, Cheung R, Mumm J, Wedemeyer H, Berenguer M, Wright T L, Davis M M and Greenberg H B 1999 Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers; Proc. Natl. Acad. Sci. USA 96 5692-5697
60. Hijikata M, Mizushima H, Akagi T, Mori S, Kakiuchi N, Kato N, Tanaka T, Kimura K and Shimotohno K 1993 Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus; J. Virol. 67 4665-4675
61. Hugle T, Fehrmann F, Bieck E, Kohara M, Krausslich H G, Rice C M, Blum H E and Moradpour D 2001 The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein; Virology 284 70-81
62. Hussy P, Langen H, Mous J and Jacobsen H 1996 Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase; Virology 224 93-104
63. Ishii K, Rosa D, Watanabe Y, Katayama T, Harada H, Wyatt C, Kiyosawa K, Aizaki H, Matsuura Y, Houghton M, Abrignani S and Miyamura T 1998 High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C; Hepatology 28 1117-1120
64. Kakumu S, Ito S, Ishikawa T, Mita Y, Tagaya T, Fukuzawa Y and Yoshioka K 2000 Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection; J. Gastroenterol. Hepatol. 15 431-436
65. Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, Sasaki Y, Kasahara A and Hori M 1999 Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals; J. Immunol. 162 5584-5591
66. Kato N, Ootsuyama Y, Ohkoshi S, Nakazawa T, Sekiya H, Hijikata M and Shimotohno K 1992 Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus; Biochem. Biophys. Res. Commun. 189 119-127
67. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S and Shimotohno K 1993 Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus; J. Virol. 67 3923-3930
68. Kato N, Yoshida H, Ono-Nita S K, Kato J, Goto T, Otsuka M, Lan K G, Matsushima K, Shiratori Y and Omata M 2000 Activation of intracellular signalling by hepatitis B and C viruses; C-viral core is the most potent signal inducer; Hepatology 32 405-412
69. Kim J L, Morgenstern K A, Lin C, Fox T, Dwyer M D, Landro J A, Chambers S P, Markland W, Lepre C A, O'Malley E T, Harbeson S L, Rice C M, Murcko M A, Caron P R and Thomson J A 1996 Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide; Cell 87 343-355
70. Kimball P, Elswick R K and Shiffman M 2001 Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon-alpha therapy; J. Med. Virol. 65 510-516
71. Kitay-Cohen Y, Amiel A, Hilzenrat N, Buskila D and Lishner M 1999 Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II; Hepatology (Suppl.) 30 238A
72. Koch J O and Bartenschlager R 1999 Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A and NS4B; J. Virol. 73 7138-7146
73. Kolykhalov A A, Feinstone S M and Rice C M 1996 Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA; J. Virol. 70 3363-3371
74. Kruger M, Beger C, Li Q X, Welch P J, Tritz R, Leavitt M, Barber J R and Wong-Staal F 2000 Identification of eIF2B-gamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach; Proc. Natl. Acad. Sci. USA 97 8566-8571
75. Kumar U, Monjardino J and Thomas H C 1994 Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient; Gastroenterology 106 1072-1075
76. Lai M M and Ware C F 2000 Hepatitis C virus core protein: possible roles in viral pathogenesis; Curr. Top. Microbiol. Immunol. 242 117-134
77. Lai M M C 2000 Hepatitis C Virus Proteins: Direct Link to Hepatic Oxidative Stress, Steatosis, Carcinogenesis and More; Gastroenterology 122 568-570
78. Lanford R E, Bigger C, Bassett S and Klimpel G 2001 The chimpanzee model of hepatitis C virus infections; Ilar J. 42 117-126
79. Large M K, Kittlesen D J and Hahn Y S 1999 Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence; J. Immunol. 162 931-938
80. Laskus T, Radkowski M, Wilkinson J, Vargas H and Rakela J 2002 The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus; J. Infect. Dis. 185 417-421
81. Lechner F, Wong D K, Dunbar P R, Chapman R, Chung R T, Dohrenwend P, Robbins G, Phillips R, Klenerman P and Walker B D 2000 Analysis of successful immune responses in persons infected with hepatitis C virus; J. Exp. Med. 191 1499-1512
82. Lerat H, Berby F, Trabaud M A, Vidalin O, Major M, Trepo C and Inchauspe G 1996 Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells; J. Clin. Invest. 97 845-851
83. Liang T J, Rehermann B, Seeff L B and Hoofnagle J H 2000 Pathogenesis, natural history, treatment and prevention of hepatitis C; Ann. Internal Med. 132 296-305
84. Liberman E, Fong Y L, Selby M J, Choo Q L, Cousens L, Houghton M and Yen T S 1999 Activation of the grp78 and grp94 promoters by hepatitis C virus E2 envelope protein; J. Virol. 73 3718-3722
85. Liu Q, Tackney C, Bhat R A, Prince A M and Zhang P 1997 Regulated processing of hepatitis C virus core protein is linked to subcellular localization; J. Virol. 71 657-662
86. Liu Z X, Nishida H, He J W, Lai M M, Feng N and Dennert G 2002 Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity; J. Virol. 76 990-997
87. Lo S and Lin H H 2001 Variations within hepatitis C virus E2 protein and response to interferon treatment; Virus Res. 75 107-112
88. Lo S Y, Selby M, Tong M and Ou J H 1994 Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution; Virology 199 124-131
89. Lohmann, V, Korner F, Dobierzewska A and Bartenschlager R 2001 Mutations in hepatitis C virus RNAs conferring cell culture adaptation; J. Virol. 75 1437-1449
90. Lohmann V, Korner F, Koch J, Herian U, Theilmann L and Bartenschlager R 1999 Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line; Science 285 110-113
91. Luo G 1999 Cellular proteins bind to the poly U tract of the 3′ untranslated region of hepatitis C virus RNA genome; Virology 256 105-118
92. Major M E and Feinstone S M 1997 The molecular virology of hepatitis C; Hepatology 25 1527-1538
93. Marusawa H, Hijikata M, Chiba T and Shimotohno K 1999 Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation; J. Virol. 73 4713-4720
94. Matsumoto M, Hsieh T Y, Zhu N, VanArsdale T, Hwang S B, Jeng K S, Gorbalenya A E, Lo S Y, Ou J H, Ware C F and Lai M M 1997 Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor; J. Virol. 71 1301-1309
95. McHutchison J G, Gordon S C, Schiff E R, Shiffman M L, Lee W M, Rustgi V K, Goodman Z D, Ling M H, Cort S and Albrecht J K 1998 Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C Hepatitis Interventional Therapy Group [see comments]; N. Engl. J. Med. 339 1485-1492
96. Mercer D F, Schiller D E, Elliott J F, Douglas D N, Hao C, Rinfret A, Addison W R, Fischer K P, Churchill T A, Lakey J R, Tyrrell D L and Kneteman N M 2001 Hepatitis C virus replication in mice with chimeric human livers; Nat. Med. 7 927-933
97. Mizutani T, Kato N, Saito S, Ikeda M, Sugiyama K and Shimotohno K 1996 Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2; J. Virol. 70 7219-7223
98. Monteverde A, Ballare M and Pileri S 1997 Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia; Springer Semin Immunopathol. 19 99-110
99. Naganuma A, Nozaki A, Tanaka T, Sugiyama K, Takagi H, Mori M, Shimotohno K and Kato N 2000 Activation of the Interferon-Inducible 2′-5′-oligoadenylate synthetase gene by hepatitis C virus core protein; J. Virol. 74 8744-8750
100. Nakajima N, Hijikata M, Yoshikura H and Shimizu Y K 1996 Characterization of long-term cultures of hepatitis C virus; J. Virol. 70 3325-3329
101. Napoli J, Bishop G A, McGuinness P H, Painter D M and McCaughan G W 1996 Progressive liver injury ifi chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines; Hepatology 24 759-765
102. Neuman M G, Benhamou J P, Malkiewicz I M, Akremi R, Shear N H, Asselah T, Ibrahim A, Boyer N, Martinot-Peignoux M, Jacobson-Brown P, Katz G G, Le Breton V, Le Guludec G, Suneja A and Marcellin P 2001 Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C; Clin. Biochem. 34 173-182
103. Ogata N, Alter H J, Miller R H and Purcell R H 1991 Nucleotide sequence and mutation rate of the H strain of hepatitis C virus; Proc. Natl. Acad. Sci. USA 88 3392-3396
104. Oh J W, Ito T and Lai M M 1999 A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA; J. Virol. 73 7694-7702
105. Oh J W, Sheu G T and Lai M M 2000 Template requirement and initiation site selection by hepatitis C virus polymerase on a minimal viral RNA template; J. Biol. Chem. 275 17710-17717
106. Park J S, Yang J M and Min M K 2000 Hepatitis C virus non-structural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene; Biochem. Biophys. Res. Commun. 267 581-587
107. Paul W E 1999 Fundamental immunology 4th edition (Philadelphia: Lippincott-Raven)
108. Pavio N, Taylor D R and Lai M M 2002 Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR; J. Virol. 76 1265-1272
109. Pestova T V, Shatsky I N, Fletcher S P, Jackson R J and Hellen C U 1998 A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs; Genes Dev. 12 67-83
110. Pietschmann T, Lohmann V, Kaul A, Krieger N, Rinck G, Rutter G, Strand D and Bartenschlager R 2002 Persistent and transient replication of full-length hepatitis C virus genomes in cell culture; J. Virol. 76 4008-4021
111. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner A J, Houghton M, Rosa D, Grandi G and Abrignani S 1998 Binding of hepatitis C virus to CD81; Science 282 938-941
112. Pioltelli P, Zehender G, Monti G, Monteverde A and Galli M 1996 HCV and non-Hodgkin lymphoma; Lancet 347 624-625
113. Podevin P, Sabile A, Gajardo R, Delhem N, Abadie A, Lozach P Y, Beretta L and Brechot C 2001 Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner; Hepatology 33 1503-1511
114. Polyak S J, Khabar K S, Paschal D M, Ezelle H J, Duverlie G, Barber G N, Levy D E, Mukaida N and Gretch D R 2001a Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response; J. Virol. 75 6095-6106
115. Polyak S J, Khabar K S, Rezeiq M and Gretch D R 2001b Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy; J. Virol. 75 6209-6211
116. Poynard T, Marcellin P, Lee S S, Niederau C, Minuk G S, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C and Albrecht J 1998 Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus International Hepatitis Interventional Therapy Group (IHIT); Lancet 352 1426-1432
117. Pozzato G, Mazzaro C, Crovatto M, Modolo M L, Ceselli S, Mazzi G, Sulfaro S, Franzin F, Tulissi P and Moretti M 1994 Low-grade malignant lymphoma, hepatitis C virus infection and mixed cryoglobulinemia; Blood 84 3047-3053
118. Puig-Basagoiti F, Saiz J C, Forns X, Ampurdanes S, Gimenez-Barcons M, Franco S, Sanchez-Fueyo A, Costa J, Sanchez-Tapias J M and Rodes J 2001 Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis C virus on the response to interferon therapy in chronic hepatitis C; J. Med. Virol. 65 35-44
119. Quinn E R, Chan C H, Hadlock K G, Foung S K, Flint M and Levy S 2001 The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis; Blood 98 3745-3749
120. Ray R B, Lagging L M, Meyer K, Steele R and Ray R 1995 Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein; Virus Res. 37 209-220
121. Ray R B, Lagging L M, Meyer K and Ray R 1996 Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype; J. Virol. 70 4438-4443
122. Ray R B, Steele R, Meyer K and Ray R 1997 Transcriptional repression of p53 promoter by hepatitis C virus core protein; J. Biol. Chem. 272 10983-10986
123. Ray R B, Steele R, Meyer K and Ray R 1998 Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity; Gene 208 331-336
124. Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, Dong C, Weiner A J, Lau J Y, Choo Q L, Chien D, Pileri P, Houghton M and Abrignani S 1996 A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells; Proc. Natl. Acad. Sci. USA 93 1759-1763
125. Ruggieri A, Harada T, Matsuura Y and Miyamura T 1997 Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein; Virology 229 68-76
126. Sakamuro D, Furukawa T and Takegami T 1995 Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells; J. Virol. 69 3893-3896
127. Santolini E, Migliaccio G and La Monica N 1994 Biosynthesis and biochemical properties of the hepatitis C virus core protein; J. Virol. 68 3631-3641
128. Sarih M, Bouchrit N and Benslimane A 2000 Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection; Immunol. Lett. 74 117-120
129. Schiappa D A, Mittal C, Brown J A and Mika B P 2002 Relationship of Hepatitis C Genotype 1 NS5A Sequence Mutations to Early Phase Viral Kinetics and Interferon Effectiveness; J. Infect. Dis. 185 868-877
130. Schmidt-Mende J, Bieck E, Hugle T, Penin F, Rice C M, Blum H E and Moradpour D 2001 Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase; J. Biol. Chem. 276 44052-44063
131. Shapiro S, Gershtein V, Elias N, Zuckerman E, Salman N and Lahat N 1998 mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment; Clin. Exp. Immunol. 114 55-60
132. Shi S T and Lai M M 2001 Hepatitis C viral RNA: challenges and promises; Cell. Mol. Life Sci. 58 1276-1295
133. Shi S T, Polyak S J, Tu H, Taylor D R, Gretch D R and Lai M M C 2002 Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins; Virology 292 198-210
134. Simmonds P 1994 Variability of hepatitis C virus genome; Curr. Stud. Hematol. Blood Transfusion 61 12-35
135. Simmonds P, Holmes E C, Cha T A, Chan S W, McOmish F, Irvine B, Beall E, Yap P L, Kolberg J and Urdea M S 1993 Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region; J. Gen. Virol. 74 2391-2399
136. Simmonds P, Smith D B, McOmish F, Yap P L, Kolberg J, Urdea M S and Holmes E C 1994 Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions; J. Gen. Virol. 75 1053-1061
137. Sizova D V, Kolupaeva V G, Pestova T V, Shatsky I N and Hellen C U 1998 Specific interaction of eukaryotic translation initiation factor 3 with the 5′ nontranslated regions of hepatitis C virus and classical swine fever virus RNAs; J. Virol. 72 4775-4782
138. Sun J, Bodola F, Fan X, Irshad H, Soong L, Lemon S M and Chan T-H 2001 Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection; J. Virol. 75 11992-11998
139. Sung V M-H, Shimodaira S, Doughty A L, Picchio G R, Can H, Yen T-S B, Lindsay K L, Levine A M and Lai M M C 2003 Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: The apoptotic effects of virus infection; J. Virol. 77 2134-2146
140. Suzuki R, Matsuura Y, Suzuki T, ando A, Chiba J, Harada S, Saito I and Miyamura T 1995 Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted; J. Gen. Virol. 76 53-61
141. Tai C L, Chi W K, Chen D S and Hwang L H 1996 The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3); J. Virol. 70 8477-8484
142. Tan S L, Nakao H, He Y, Vijaysri S, Neddermann P, Jacobs B L, Mayer B J and Katze M G 1999 NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling; Proc. Natl. Acad. Sci. USA 96 5533-5538
143. Taylor D R, Shi S T, Romano P R, Barber G N and Lai M M 1999 Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein; Science 285 107-110
144. Tsai S L, Chen Y M, Chen M H, Huang C Y, Sheen I S, Yeh C T, Huang J H, Kuo G C and Liaw Y F 1998 Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity; Gastroenterology 115 954-965
145. Tseng C T and Klimpel G R 2002 Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions; J. Exp. Med. 195 43-49
146. Tu H, Gao L, Shi S T, Taylor D R, Yang T, Mircheff A K, Wen Y, Gorbalenya A E, Hwang S B and Lai M M C 1999 Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein; Virology 263 30-41
147. Valiante N M, D'Andrea A, Crotta S, Lechner F, Klenerman P, Nuti S, Wack A and Abrignani S 2000 Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C; Immunol. Rev. 174 77-89
148. Wack A, Soldaini E, Tseng C, Nuti S, Klimpel G and Abrignani S 2001 Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells; Eur. J. Immunol. 31 166-175
149. Watashi K, Hijikata M, Marusawa H, Doi T and Shimotohno K 2001 Cytoplasmic localization is important for transcription factor nuclear factor-kappa B activation by hepatitis C virus core protein through its amino terminal region; Virology 286 391-402
150. Weiner A, Erickson A L, Kansopon J, Crawford K, Muchmore E, Hughes A L, Houghton M and Walker C M 1995 Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant; Proc. Natl. Acad. Sci. USA 92 2755-2759
151. Weiner A J, Brauer M J, Rosenblatt J, Richman K H, Tung J, Crawford K, Bonino F, Saracco G, Choo Q L, Houghton M et al 1991 Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins; Virology 180 842-858
152. Weiner A J, Geysen H M, Christopherson C, Hall J E, Mason T J, Saracco G, Bonino F, Crawford K, Marion C D, Crawford K A et al 1992 Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections; Proc. Natl. Acad. Sci. USA 89 3468-3472
153. Yamashita T, Kaneko S, Shirota T, Qin W, Nomura T, Kobayashi K and Murakami S 1998 RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region; J. Biol. Chem. 273 15479-15486
154. Yanagi M, Purcell R H, Emerson S U and Bukh J 1997 Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee; Proc. Natl. Acad. Sci. USA 94 8738-8743
155. Yanagi M, Purcell R H, Emerson S U and Bukh J 1999a Hepatitis C virus: an infectious molecular clone of a second major genotype 2a and lack of viability of intertypic 1a and 2a chimeras; Virology 262 250-263
156. Yanagi M, St Claire M, Emerson S U, Purcell R H and Bukh J 1999b In vivo analysis of the 3′ untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone; Proc. Natl. Acad. Sci. USA 96 2291-2295
157. Yanagi M, St Claire M, Shapiro M, Emerson S U, Purcell R H and Bukh J 1998 Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo; Virology 244 161-172
158. Yao Z Q, Nguyen D T, Hiotellis A I and Hahn Y S 2001 Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway; J. Immunol. 167 5264-5272
159. Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C and Lai M M 1998 Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis; J. Virol. 72 3691-3697
160. Zhu N, Ware C F and Lai M M 2001 Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor; Virology 283 178-187
161. Zignego A L, Giannelli F, Marrocchi M E, Mazzocca A, Ferri C, Giannini C, Monti M, Caini P, Villa G L, Laffi G and Gentilini P 2000 T(14;18) translocation in chronic hepatitis C virus infection; Hepatology 31 474-479
162. Zuckerman E, Zuckerman T, Levine A M, Douer D, Gutekunst K, Mizokami M, Qian D G, Velankar M, Nathwani B N and Fong T L 1997 Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma; Ann. Int. Med. 127 423-428
163. Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E, Yeshurun D and Rowe J 2001 bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection; Br. J. Haematol. 112 364-369